Breaking News

Camargo to Acquire InSymbiosis

Acquisition aims to improve how biopharma companies outsource R&D

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Camargo Pharmaceutical Services, a drug development and commercialization partner, will acquire InSymbiosis, a Canadian drug development company, to improve how biopharma companies outsource R&D.  InSymbiosis was founded in 2005, and is managed by ex-pharma and contract research organization drug development scientists and executives. Based in Montreal, the team includes a multidisciplinary drug development group, financial and investment experts, and a strong project management team. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters